EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Bone marrow biopsy can be omitted in the diagnostic workup of CNS lymphoma of DLBCL origin: a population-based retrospective study in the PET-CT era

Jelena Jelicic, Dennis Lund Hansen, Sarah Sand Carlsen, Michael Thorsgaard, Ditte Stampe Hersby, Karina Kannik, Amalie Sofie Eilsø Munksgaard, Thomas Stauffer Larsen, Karen Juul-Jensen

Annals of Hematology · 2023

DOI: 10.1007/s00277-023-05282-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Hematology, 2023. Verfasst von Jelena Jelicic und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Odense University Hospital, Odense, Denmark. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Lymphoma, Large B-Cell, Diffuse. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Odense University Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Currently, bone marrow (BM) biopsy (BMB) is recommended in the initial staging of patients with the presumed primary central nervous system (CNS) lymphoma (PCNSL). However, the added value of BMB in the era of positron emission tomography ( PET-CT) has been challenged in other lymphoma subtypes. We analyzed BM findings in patients with biopsy-proven CNS lymphoma and a negative PET-CT scan for disease outside CNS. A comprehensive Danish population-based registry search was performed to identify all patients with CNS lymphoma of diffuse large B cell lymphoma (DLBCL) histology with available BMB results and staging PET-CT without systemic lymphoma. A total of 300 patients fulfilled the inclusion criteria. Of them, 16% had a previous history of lymphoma, while 84% were diagnosed with PCNSL. None of the patients had DLBCL in the BM. A minority (8.3%) had discordant BMB findings, mainly low-grade histologies that did not influence treatment choice in any case. In conclusion, the risk of overlooking concordant BM infiltration in patients with CNS lymphoma of DLBCL histology and negative PET-CT scan is negligible. As we did not find any patient with DLBCL in the BMB, our results suggest that BMB can be safely omitted in the diagnostic workup in patients with CNS lymphoma and a negative PET-CT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron Emission Tomography Computed TomographyLymphoma, Large B-Cell, DiffuseHumansBone MarrowRetrospective StudiesFluorodeoxyglucose F18Positron-Emission TomographyBiopsy

Stichwörter der Autor:innen

Bone marrow biopsyCentral nervous system lymphomaDiffuse large B cell lymphomaPET-CT

Substanzen

Fluorodeoxyglucose F18

Autor:innen und Institutionen

  • Department of Hematology, Odense University Hospital, Odense, Denmark.
  • Department of Hematology Vejle Hospital, Vejle, Denmark.
  • Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
  • Department of Hematology, Zeeland University Hospital, Roskilde, Denmark.
  • Department of Hematology, Aarhus University Hospital, Aarhus, Denmark.
  • Department of Hematology, Copenhagen University Hospital, Rigshospitalet, Denmark.

Förderung

  • Odense University Hospital

Zitieren

APA

Jelicic, J., Hansen, D. L., Carlsen, S. S., Thorsgaard, M., Hersby, D. S., Kannik, K., Munksgaard, A. S. E., Larsen, T. S., & Juul-Jensen, K. (2023). Bone marrow biopsy can be omitted in the diagnostic workup of CNS lymphoma of DLBCL origin: a population-based retrospective study in the PET-CT era. Annals of Hematology. https://doi.org/10.1007/s00277-023-05282-7

Vancouver

Jelicic J, Hansen DL, Carlsen SS, Thorsgaard M, Hersby DS, Kannik K, et al. Bone marrow biopsy can be omitted in the diagnostic workup of CNS lymphoma of DLBCL origin: a population-based retrospective study in the PET-CT era. Annals of Hematology. 2023. doi:10.1007/s00277-023-05282-7

BibTeX
@article{Jelicic2023,
  author = {Jelicic, Jelena and Hansen, Dennis Lund and Carlsen, Sarah Sand and Thorsgaard, Michael and Hersby, Ditte Stampe and Kannik, Karina and Munksgaard, Amalie Sofie Eilsø and Larsen, Thomas Stauffer and Juul-Jensen, Karen},
  title = {Bone marrow biopsy can be omitted in the diagnostic workup of CNS lymphoma of DLBCL origin: a population-based retrospective study in the PET-CT era},
  journal = {Annals of Hematology},
  year = {2023},
  doi = {10.1007/s00277-023-05282-7}
}
Kostenlos starten →